Neurotensin Agonists: Potential in the Treatment of Schizophrenia

By Boules Mona  

CNS Drugs, Vol. 21, Iss. 1, 2007-01 ,pp. : 13-23

Adis International

Access to resources Recommend Favorite

Clinical Potential of Neuropeptide Y Receptor Ligands in the Treatment of Epilepsy

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 17, 2007-09 ,pp. : 1660-1674

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacology of neuropeptide Y receptor antagonists - Focus on cardiovascular functions

By Malmstrom R.E.  

European Journal of Pharmacology, Vol. 447, Iss. 1, 2002-06 ,pp. : 11-30

Elsevier

Access to resources Recommend Favorite

Neuropeptide Mimetics and Antagonists in the Treatment of Inflammatory Disease: Focus on VIP and PACAP

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-01 ,pp. : 151-163

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Receptors and the Treatment of Attentional and Cognitive Deficits in Neuropsychiatric Disorders: Focus on the 7 Nicotinic Acetylcholine Receptor as a Promising Drug Target for Schizophrenia

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 4, 2007-12 ,pp. : 269-288

Bentham Science Publishers

Access to resources Recommend Favorite